• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ADVANIX BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ADVANIX BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number 3428
Medical Device Problem Codes Break (1069); Difficult to Remove (1528)
Health Effect - Clinical Codes Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/05/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported to boston scientific corporation that an advanix biliary stent was initially implanted during an endoscopic retrograde cholangiopancreatography (ercp) procedure in the common bile duct, performed on (b)(6) 2022.On (b)(6) 2022, a planned stent removal procedure was performed.When the physician attempted to remove the stent with a pair of rat tooth, the stent was difficult to remove and a part of the stent tore off and was left in the common bile duct.The procedure was completed leaving the broken piece of stent in the patient and it was reported that the patient was referred to another facility to perform an additional procedure of sphincterotomy by doing a balloon sweep to remove the broken biliary stent.There were no patient complications reported as a result of this event.
 
Event or Problem Description
It was reported to boston scientific corporation that an advanix biliary stent was initially implanted during an endoscopic retrograde cholangiopancreatography (ercp) procedure in the common bile duct, performed on (b)(6) 2022.On (b)(6) 2022, a planned stent removal procedure was performed.When the physician attempted to remove the stent with a pair of rat tooth, the stent was difficult to remove and a part of the stent tore off and was left in the common bile duct.The procedure was completed leaving the broken piece of stent in the patient and it was reported that the patient was referred to another facility to perform an additional procedure of sphincterotomy by doing a balloon sweep to remove the broken biliary stent.There were no patient complications reported as a result of this event.
 
Additional Manufacturer Narrative
Block h6: medical device problem code a0401 captures the reportable event of stent break.Medical device problem code a150207 captures the reportable event of stent difficult to remove.Patient code e2008 captures the reportable event of un-retrieved device fragment.Impact code f05 delay to treatment/therapy captures the reportable event of delay to treatment/therapy.Impact code f23 captures the reportable event of unexpected medical intervention.Conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANIX BILIARY
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key14553107
Report Number3005099803-2022-02824
Device Sequence Number12147874
Product Code FGE
UDI-Device Identifier08714729787372
UDI-Public08714729787372
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K101314
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/01/2023
Device Model Number3428
Device Catalogue NumberM00534280
Device Lot Number0027072803
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 05/05/2022
Supplement Date Received by Manufacturer07/06/2022
Initial Report FDA Received Date05/31/2022
Supplement Report FDA Received Date08/01/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/01/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-